scispace - formally typeset
Open AccessJournal ArticleDOI

The Role of Galectins as Modulators of Metabolism and Inflammation.

TLDR
Information on galectin-1, -2, -3, -4, -7, -8, -9, and -12 can all induce T-cell apoptosis and modulate inflammation and the potential to target galectins for therapeutic purposes is presented.
Abstract
Galectins are β-galcotosid-binding lectins. The function of galectins varies with their tissue-specific and subcellular location, and their binding to carbohydrates makes them key players in several intra- and extracellular processes where they bind to glycosylated proteins and lipids. In humans, there are 12 identified galectins, some with tissue-specific distribution. Galectins are found inside cells and in the nucleus, cytosol, and organelles, as well as extracellularly. Galectin-1, -2, -3, -4, -7, -8, -9, and -12 can all induce T-cell apoptosis and modulate inflammation. In the context of metabolic control and loss of the same in, for example, diabetes, galectin-1, -2, -3, -9, and -12 are especially interesting. This review presents information on galectins relevant to the control of inflammation and metabolism and the potential to target galectins for therapeutic purposes.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Galectin-1 as an Emerging Mediator of Cardiovascular Inflammation: Mechanisms and Therapeutic Opportunities

TL;DR: The emerging roles of Gal-1 in cardiovascular diseases including acute myocardial infarction, heart failure, Chagas cardiomyopathy, pulmonary hypertension, and ischemic stroke are discussed, highlighting underlying anti-inflammatory mechanisms and therapeutic opportunities.
Journal ArticleDOI

Targeting Galectins With Glycomimetics.

TL;DR: The last approaches toward the specific design of glycomimetics as potential drugs against galectins are gathered, from the employment of S-glycosyl compounds to peptidomimetics and multivalent glycopolymers, mostly employed to recognize and/or detect hGal-1 and h Gal-3.
Journal ArticleDOI

Roles of galectin-3 in metabolic disorders and tumor cell metabolism.

TL;DR: A brief review summarizes the current understanding of the roles and actions of galectin-3 in these metabolic diseases and in tumor metabolism.
References
More filters
Journal ArticleDOI

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

TL;DR: It is proposed that obesity-related insulin resistance is, at least in part, a chronic inflammatory disease initiated in adipose tissue, and that macrophage-related inflammatory activities may contribute to the pathogenesis of obesity-induced insulin resistance.
Journal ArticleDOI

Apoptosis of T cells mediated by galectin-1

TL;DR: Galectin-1 induced apoptosis of activated human T cells and human T leukaemia cell lines and represents a new mechanism for regulating the immune response.
Journal ArticleDOI

Galectin-3: an open-ended story.

TL;DR: Through specific interactions with a variety of intra- and extracellular proteins galectin-3 affects numerous biological processes and seems to be involved in different physiological and pathophysiological conditions, such as development, immune reactions, and neoplastic transformation and metastasis.
Journal ArticleDOI

Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential

TL;DR: Natural killer cells constitute 50–90% of lymphocytes in human uterine decidua in early pregnancy and are compared with the CD56bright and CD56dim peripheral NK cell subsets by microarray analysis, with verification of results by flow cytometry and RT-PCR.
Journal ArticleDOI

Protein glycation, diabetes, and aging.

TL;DR: A new class of agents, exemplified by 4,5-dimethyl-3-phenacylthiazolium chloride (DPTC), which can chemically break already-formed AGE protein-protein crosslinks, are developed, based on a new theory of AGE crosslinking that postulates that alpha-dicarbonyl structures are present in AGEprotein- protein crosslinks.
Related Papers (5)